21 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07578 | R-DIM-P-LF11 | FQWQRNIRKVRPRVKRINRQWQF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 = 125.0 ± 16.8 μM |
| dbacp07579 | R-DIM-P-LF11 | FQWQRNIRKVRPRVKRINRQWQF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 = 10.7 ± 0.2 μM |
| dbacp07580 | R-DIM-P-LF11 | FQWQRNIRKVRPRVKRINRQWQF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 20.9 ± 3.9 μM |
| dbacp07581 | R-DIM-P-LF11-322 | PFWRIRIRRPRRIRIRWFP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 = 4.2 ± 0.2 μM |
| dbacp07582 | R-DIM-P-LF11-322 | PFWRIRIRRPRRIRIRWFP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 = 2.5 ± 0.1 μM |
| dbacp07583 | R-DIM-P-LF11-322 | PFWRIRIRRPRRIRIRWFP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 4.7 ± 0.2 μM |
| dbacp07584 | DIM-LF11-322 | PFWRIRIRRPFWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 = 6.3 ± 0.3 μM |
| dbacp07585 | DIM-LF11-322 | PFWRIRIRRPFWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 < 1 ± 0.0 μM |
| dbacp07586 | DIM-LF11-322 | PFWRIRIRRPFWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 4.6 ± 0.1 μM |
| dbacp07587 | R-DIM-P-LF11-215 | FWRIRIRRPRRIRIRWF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 = 2.7 ± 0.9 μM |
| dbacp07588 | R-DIM-P-LF11-215 | FWRIRIRRPRRIRIRWF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 < 1 ± 0.0 μM |
| dbacp07589 | R-DIM-P-LF11-215 | FWRIRIRRPRRIRIRWF | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 4.6 ± 0.1 μM |
| dbacp07590 | R-DIM-P-LF11-334 | PWRIRIRRPRRIRIWP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 = 6.6 ± 0.3 μM |
| dbacp07591 | R-DIM-P-LF11-334 | PWRIRIRRPRRIRIWP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 = 3.4 ± 0.4 μM |
| dbacp07592 | R-DIM-P-LF11-334 | PWRIRIRRPRRIRIWP | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 5.0 ± 0.1 μM |
| dbacp07593 | R-DIM-LF11-334-LF11-334 | PWRIRIRRRRIRIRWPPWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 < 1 ± 0.1 μM |
| dbacp07594 | R-DIM-LF11-334-LF11-334 | PWRIRIRRRRIRIRWPPWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 < 1 ± 0.1 μM |
| dbacp07595 | R-DIM-LF11-334-LF11-334 | PWRIRIRRRRIRIRWPPWRIRIRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 3.6 ± 0.7 μM |
| dbacp07596 | DIM-LF11-339 | RRWFWRRRRWFWRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | A-375 | Skin Cancer | LC50 = 4.8 ± 0.4 μM |
| dbacp07597 | DIM-LF11-339 | RRWFWRRRRWFWRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | SBcl2 | Skin Cancer | LC50 = 4.7 ± 0.3 μM |
| dbacp07598 | DIM-LF11-339 | RRWFWRRRRWFWRR | Synthetic | Peptides target phosphatidylserine, trigger apoptosis | MTS assay | WM164 | Skin Cancer | LC50 = 3.8 ± 0.3 μM |